Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $13.46, but opened at $15.12. Oscar Health shares last traded at $15.75, with a volume of 3,565,490 shares.
Analysts Set New Price Targets
OSCR has been the subject of a number of research reports. Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $21.56.
Get Our Latest Report on OSCR
Oscar Health Price Performance
The company has a 50 day moving average price of $14.82 and a 200-day moving average price of $16.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.66 billion, a price-to-earnings ratio of -740.33 and a beta of 1.73.
Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Insider Buying and Selling at Oscar Health
In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares of the company's stock, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the transaction, the insider now owns 81,962 shares in the company, valued at $1,481,872.96. The trade was a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 78,610 shares of company stock valued at $1,421,269. 25.11% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Oscar Health
A number of institutional investors and hedge funds have recently modified their holdings of the business. Toronto Dominion Bank bought a new position in shares of Oscar Health during the 4th quarter worth approximately $1,008,000. Tidal Investments LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $419,000. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Scion Asset Management LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $2,688,000. Finally, Southeastern Asset Management Inc. TN boosted its holdings in shares of Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after buying an additional 1,073,359 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
